Quantcast

Latest Riociguat Stories

2014-05-12 23:08:41

Pulmonary arterial hypertension – a deadly, incurable lung condition – is one of only sixteen disease states FDA will focus on during the first three years of the Patient Focused Drug Development Initiative. The meeting represents a historic opportunity for patient input. Silver Spring, MD (PRWEB) May 12, 2014 On Tuesday, May 13, the Food and Drug Administration and the Pulmonary Hypertension Association will host a unique conversation between FDA drug reviewers and pulmonary arterial...

2014-03-10 08:22:19

-- Bayer's Adempas (riociguat tablets) approved for the treatment of pulmonary arterial hypertension (PAH)(1), which affects up to 2000 Canadians(2) -- Adempas provides novel and specific approach to treat different types of pulmonary hypertension (PH), a serious condition of the heart and lungs -- Only drug in Canada indicated to treat two rare types of PH - PAH and chronic thromboembolic pulmonary hypertension (CTEPH)(1,3) TORONTO, March...

2013-10-11 23:19:10

Only a handful of the 7,000 rare diseases in the US have more than one treatment, and most have none. Why have science and medicine grown so much in pulmonary hypertension, and how is the field addressing the next big challenge — early diagnosis? Silver Spring, MD (PRWEB) October 11, 2013 The US Food and Drug Administration yesterday approved the tenth treatment, riociguat, for pulmonary hypertension (PH), a rare and life-threatening lung disease affecting roughly 20-30,000 patients,...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related